Cancer vaccination can improve the clinical response after conventional treatment. Vaccination requires identification of known tumor antigen that can stimulate patients? immune system to launch immune reaction against the cancer cells. For cancers such as that of the kidney where such antigens are not identified, a technique is developed to produce a hybrid between the tumor cell and an immune system cell that will contain all the tumor antigens. These customized hybrid cells when infused into the patient stimulate the host immune system to destroy the tumors.
Go to Previous Page
Go to Next Page